Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Journal of Virology|April 14, 2004
Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virusJanardan P Pandey, Jacquie Astemborski, David L ThomasThe Journal of Infectious Diseases|August 19, 2011
CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis CMarija Zeremski, Rositsa Dimova, Jacquie Astemborski, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008Shruti H Mehta, Gregory D Kirk, Jacquie Astemborski, et al.Addiction (Abingdon, England)|April 8, 2015
Incarceration and injection drug use in Baltimore, MarylandBecky L Genberg, Jacquie Astemborski, David Vlahov, et al.AIDS (London, England)|June 18, 2013
Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug usersRyan P Westergaard, Timothy Hess, Jacquie Astemborski, et al.AIDS Research and Human Retroviruses|January 28, 2006
Serum albumin as a prognostic indicator for HIV disease progressionShruti H Mehta, Jacquie Astemborski, Timothy R Sterling, et al.The International Journal on Drug Policy|September 16, 2019
Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, MarylandMegan Buresh, Becky L Genberg, Jacquie Astemborski, et al.Hepatology (Baltimore, Md.)|January 31, 2004
High prevalence of occult hepatitis B in Baltimore injection drug usersMichael Torbenson, Rajesh Kannangai, Jacquie Astemborski, et al.Drug and Alcohol Review|July 1, 2024
Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, MarylandPieter Baker, Becky L Genberg, Jacquie Astemborski, et al.Journal of Addiction Medicine|November 24, 2025
A Longitudinal Analysis of PrEP Eligibility in Women With a History of Injection Drug UseEmily Hoff, Tarfa Verinumbe, Jacquie Astemborski, et al.Pageof 10